Target intelligence / Profile preview

Solute carrier family 17 member 5 (Sialin) (SLC17A5)

Target
SLC17A5
Molecular classification
Transporter, Solute carrier family
01

Overview

Solute carrier family 17 member 5 (SLC17A5), commonly known as Sialin, is a lysosomal membrane protein that functions as a transporter for sialic acid and inorganic nitrate (UniProt: Q9NRA2). In lysosomes, it exports sialic acid to the cytosol, while in the plasma membrane of salivary gland acinar cells, it acts as an electrogenic H+/nitrate cotransporter (PubMed: 22267511). This transport is a critical step in the enterosalivary circulation of nitrate, where dietary nitrate is concentrated in saliva, reduced to nitrite by oral bacteria, and further converted to nitric oxide (NO) in the acidic environment of the stomach or through systemic nitrite reductases (PubMed: 25599331). This pathway serves as an important alternative source of NO, particularly under hypoxic conditions where the canonical L-arginine-NOS pathway is impaired. Mutations in the SLC17A5 gene lead to sialic acid storage diseases, such as Salla disease and infantile sialic acid storage disease (ISSD), characterized by neurodegeneration (PubMed: 10508514). From a therapeutic perspective, Sialin is a target for modulating NO bioavailability to treat cardiovascular conditions like hypertension and endothelial dysfunction through the administration of inorganic nitrate (PubMed: 25421027).

Other names
SialinSLC17A5ASTISSDSDSLDNitrate transporterMembrane glycoprotein HP59
02

Mechanism of action

Facilitates the active transport of inorganic nitrate into salivary glands as part of the enterosalivary circulation, providing a substrate for the production of nitric oxide via the nitrate-nitrite-NO pathway.

03

Biological functions

Nitrate transportSialic acid transportNitric oxide homeostasisLysosomal effluxEnterosalivary circulation
04

Disease associations

HypertensionCardiovascular diseaseSalla diseaseInfantile sialic acid storage diseaseEndothelial dysfunction
05

Safety considerations

Risk of methemoglobinemia at high dosesPotential for hypotensionConcerns regarding the formation of carcinogenic N-nitroso compoundsGenetic risk of Salla disease if transporter function is compromised
06

Interacting drugs

Sodium nitrate

1 more in the full profile.

07

Biomarkers

Salivary nitrate levelsPlasma nitrite levelsUrinary nitrate excretionLysosomal sialic acid concentration

Beyond the preview

Go deeper on Solute carrier family 17 member 5 (Sialin) (SLC17A5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Solute carrier family 17 member 5 (Sialin) (SLC17A5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call